x min read

Stocks Cheers on Upbeat Move: Orbital Sciences Corp. (NYSE:ORB), Chevron Corporation (NYSE:CVX), Regulus Therapeutics Inc. (NASDAQ:RGLS)

Stocks Cheers on Upbeat Move: Orbital Sciences Corp. (NYSE:ORB), Chevron Corporation (NYSE:CVX), Regulus Therapeutics Inc. (NASDAQ:RGLS)
Written by
Ryan Mitchell
Published on
October 30, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Orbital Sciences Corp. (NYSE:ORB) released that Antares rocket release from NASA's Wallops Flight Facility was not successful. Shortly following lift-off from the Mid-Atlantic Regional Spaceport Pad 0A at 6:22 p.m. (EDT), the vehicle suffered a catastrophic failure. According to NASA's emergency operations officials, there were no casualties and property damage was limited to the south end of Wallops Island. Orbital Sciences Corp. (NYSE:ORB) stock hit highest price at $26.93, beginning with a price of $25.00 to the closed at 25.27 by a lose of -16.79% with a day range of $24.80-$26.93. The total market capitalization remained 1.538 Billion, total volume of 4.98 Million shares held in the session was surprisingly higher than its average volume of 339.95 shares.Chevron Corporation (NYSE:CVX) released that its subsidiary, Union Oil Company of California, has signed a final investment decision to proceed with the development of the Hess Corporation-operated Stampede project in the deepwater U.S. Gulf of Mexico. Stampede is a deepwater subsea development, which will be tied-back to a newly constructed Tension Leg Platform. On the other consideration, Chevron Corporation (NYSE:CVX) begun last trade with a price of $118.14 and throughout the trading session climbed at $118.93. The day-trade ended with an advance of 0.01% to closed at $117.14. The stock is going forward its fifty-two week low with 10.00% and lagging behind from its 52 week high price with -12.55%. CVX last month stock price volatility remained 2.15%.Regulus Therapeutics Inc. (NASDAQ:RGLS) prices 5,294,118 shares of its common stock at a price to the public of $17.00 per share by co and existing shareholder Isis Pharmaceuticals (ISIS). Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) opened at $18.73 with 43.39 million outstanding shares and hit to its highest price of $20.50 during the day and finally closed at $18.08 by scoring 2.67%. In the whole session, it traded on volume of 9.33 Million shares, which turned higher than its average volume.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You